Léa Wenger is a French clinical neuroscientist, biotechnology entrepreneur, and the co-founder and CEO of Cyclana Bio. She is recognised for her research into women’s health, particularly the development of new treatments for endometriosis. Alongside her scientific achievements, she is also known as the only child of former Arsenal manager Arsène Wenger and former French basketball player Annie Brosterhous. After completing multiple degrees and a PhD at the University of Cambridge, she built a career in neuroscience, epigenetics, and biotechnology, including work at Altos Labs. This article explores Léa Wenger’s early life, education, scientific career, Cyclana Bio leadership, personal life, estimated net worth, and contribution to modern medical research.
Quick Bio
| Attribute | Details |
| Full Name | Dr Léa Marion Denise Wenger |
| Profession | Clinical Neuroscientist, Entrepreneur, Biotech Executive |
| Known For | Co-founder and CEO of Cyclana Bio |
| Date of Birth | April 1997 |
| Age | 29 years (according to the provided source) |
| Birthplace | England |
| Nationality | French |
| Current Residence | Cambridge, England |
| Father | Arsène Wenger |
| Mother | Annie Brosterhous |
| Education | University of Cambridge |
| Bachelor’s Degree | BA in Physiology, Development and Neuroscience |
| Additional Degree | Medical Veterinary Sciences Tripos (MVST) |
| Doctorate | PhD in Clinical Neurosciences (2022) |
| Previous Employer | Altos Labs |
| Previous Research | European Bioinformatics Institute |
| Current Company | Cyclana Bio |
| Current Position | Co-founder and Chief Executive Officer (CEO) |
| Research Focus | Endometriosis, Tissue Biology, Women’s Health |
| Marital Status | Not publicly confirmed |
| Net Worth | Not publicly disclosed |
| Health Status | No publicly reported health concerns |
| Wikipedia | No dedicated Wikipedia page |
Introduction to Léa Wenger
Léa Wenger is a French clinical neuroscientist, biotechnology entrepreneur, and CEO of Cyclana Bio. She has built a distinguished scientific career through research in clinical neuroscience, epigenetics, and women’s health. After completing multiple degrees and a PhD in Clinical Neurosciences at the University of Cambridge, she worked at Altos Labs before co-founding Cyclana Bio. Her company focuses on developing innovative treatments for endometriosis using advanced tissue biology and drug discovery research. Although Léa Wenger is widely recognised as the daughter of Arsène Wenger, she has established an independent reputation through scientific innovation, academic excellence, and leadership within the biotechnology industry.
Early Life and Education
Léa Wenger was born in England in April 1997 and grew up in North London during her father’s successful career as Arsenal manager. Although she comes from a well-known sporting family, she chose to pursue science rather than professional sport. Her academic journey at the University of Cambridge reflects exceptional dedication, leading to multiple degrees and a doctorate in clinical neuroscience. This section explores her family background, university education, and outstanding academic achievements.
Childhood and Family Background
Léa Wenger is the only child of former Arsenal manager Arsène Wenger and former French Olympic basketball player Annie Brosterhous. She spent her childhood in Totteridge, North London, where she was raised while her father managed Arsenal Football Club. Despite growing up in a famous family, she has consistently preferred a private lifestyle and has focused on building her own scientific career through education and research.
University of Cambridge
Léa Wenger studied at the University of Cambridge, where she completed several demanding academic programmes over multiple years. During her time at Cambridge, she developed expertise in neuroscience, biology, and medical sciences while also participating in university leadership roles. Her education provided the scientific foundation that later supported her work in biotechnology and clinical research.
Degrees and Academic Achievement
Léa Wenger earned a BA in Physiology, Development and Neuroscience, followed by the Medical Veterinary Sciences Tripos (MVST) qualification. She later completed a PhD in Clinical Neurosciences in 2022. These achievements demonstrate her commitment to scientific research and advanced medical education. Her academic success prepared her for leadership positions in biotechnology, neuroscience, and innovative drug discovery.
Academic Research Career
Léa Wenger developed an impressive academic research career while studying at the University of Cambridge. Her work combined laboratory research, teaching, and clinical neuroscience, allowing her to build expertise before entering the biotechnology industry. She also collaborated with internationally recognised research organisations, strengthening her scientific knowledge and preparing for future leadership in medical innovation. This section explores her research experience, teaching responsibilities, and contribution to clinical neuroscience.
European Bioinformatics Institute
During her doctoral studies, Léa Wenger spent several years as a visiting researcher at the European Bioinformatics Institute (EMBL-EBI). There, she worked with advanced biological data and scientific research projects that supported modern biomedical discovery. This experience strengthened her understanding of genetics, computational biology, and disease research while expanding her expertise beyond traditional laboratory neuroscience.
Embryology Supervisor
Alongside her research, Léa Wenger served as an Embryology Supervisor at the University of Cambridge. In this academic role, she supported students by teaching embryology concepts and supervising laboratory learning. The position reflected both her scientific knowledge and her ability to communicate complex biological subjects clearly within a university environment.
Clinical Neuroscience Research
Léa Wenger focused her doctoral research on clinical neurosciences, studying biological mechanisms linked to human health and disease. Her research combined neuroscience with advanced laboratory methods to improve scientific understanding of medical conditions. Completing her PhD in Clinical Neurosciences in 2022 provided the foundation for her later work in biotechnology, drug discovery, and innovative therapies for women’s health.
Professional Career
Léa Wenger has built a successful professional career by combining scientific research with biotechnology entrepreneurship. After completing her doctorate, she worked in advanced cellular research before launching her own biotechnology company. Her work focuses on developing innovative treatments for women’s health conditions through scientific discovery and modern drug development. This section explores her work at Altos Labs, her research in epigenetics, and her leadership within the biotechnology sector.
Altos Labs
Following the completion of her PhD in Clinical Neurosciences in 2022, Léa Wenger joined Altos Labs, a biotechnology company specialising in cellular rejuvenation research. As an epigenetics scientist, she worked on projects exploring the biological processes linked to ageing and disease. This role expanded her expertise in advanced biomedical research before she moved into biotechnology entrepreneurship.
Epigenetics Research
At Altos Labs, Léa Wenger focused on epigenetics, a scientific field that studies how gene activity changes without altering DNA sequences. Her research explored cellular ageing, disease mechanisms, and potential therapeutic approaches. This experience strengthened her understanding of regenerative biology and provided valuable knowledge for developing future medical treatments through biotechnology.
Biotechnology Leadership
Léa Wenger’s scientific background naturally led her into biotechnology leadership. Combining academic research with industry experience, she developed the skills needed to guide innovative healthcare projects. Her transition from researcher to entrepreneur reflects her commitment to translating scientific discoveries into practical therapies that address unmet medical needs, particularly within women’s health and chronic disease research.
Cyclana Bio
Léa Wenger is the co-founder and Chief Executive Officer of Cyclana Bio, a Cambridge-based biotechnology company focused on developing new treatments for endometriosis. The company combines tissue biology, extracellular matrix research, and drug discovery to address a condition that has historically received limited scientific attention. Through her leadership, Léa Wenger is helping transform laboratory research into practical healthcare solutions. This section explores the creation of Cyclana Bio, her leadership role, the company’s scientific mission, and its reported funding.
Co-founding Cyclana Bio
After gaining experience in academic research and biotechnology, Léa Wenger co-founded Cyclana Bio to improve treatment options for women living with endometriosis. The company was established to bridge the gap between scientific discovery and patient care. Her decision to launch the business reflects a commitment to solving complex medical challenges through innovative research and biotechnology.
CEO Role
As Chief Executive Officer, Léa Wenger leads the company’s scientific direction, business strategy, and long-term development. She works with researchers, investors, and healthcare specialists to advance new therapeutic programmes. Her role combines scientific expertise with leadership, ensuring that research projects move efficiently from laboratory studies towards future clinical applications.
Endometriosis Drug Discovery
Cyclana Bio focuses on discovering new therapies for endometriosis, a chronic inflammatory condition affecting millions of women worldwide. The company studies tissue biology and the extracellular matrix to better understand how the disease develops. This research aims to identify innovative treatments that address the underlying biological causes rather than simply managing symptoms.
Funding and Growth
Cyclana Bio has attracted significant early support for its scientific research. According to public reports, the company secured £5 million in funding through the Babraham innovation ecosystem to accelerate its drug discovery programmes. This investment supports laboratory research, technology development, and the expansion of therapeutic projects focused on improving women’s health through biotechnology.
Sports Leadership
Léa Wenger demonstrated strong leadership beyond the laboratory through her involvement in university athletics. Alongside her scientific studies, she held several leadership positions that promoted teamwork, wellbeing, and women’s participation in sport. These experiences helped develop management, communication, and organisational skills that later supported her role as a biotechnology entrepreneur. This section explores her leadership within the Cambridge University Athletic Club and The Ospreys.
Cambridge University Athletic Club
Léa Wenger served in several leadership positions within the Cambridge University Athletic Club (CUAC), including Women’s Captain, Welfare Officer, and later President. These responsibilities involved supporting student athletes, promoting wellbeing, and helping organise club activities. Her leadership reflected a commitment to teamwork, inclusion, and excellence alongside her demanding academic and scientific work.
The Ospreys
Léa Wenger also served as President of The Ospreys, a Cambridge society that supports and celebrates women’s achievement in sport. Through this role, she encouraged greater participation, recognised athletic success, and promoted leadership opportunities for female students. Her involvement demonstrated a strong commitment to empowering women both inside and outside academic life.
Leadership Experience
Holding leadership positions in both CUAC and The Ospreys helped Léa Wenger develop valuable organisational and management skills. Balancing these responsibilities with advanced scientific research required discipline, collaboration, and effective decision-making. These experiences complemented her academic achievements and prepared her for leading Cyclana Bio as a biotechnology entrepreneur and chief executive.
Personal Life
Léa Wenger maintains a very private personal life despite coming from one of football’s most recognised families. Although she is the daughter of former Arsenal manager Arsène Wenger, she has built her own identity through science and entrepreneurship rather than public attention. Most of her public profile centres on research, biotechnology, and leadership. This section explores her family background, relationship status, and preference for keeping her private life away from media coverage.
Family
Léa Wenger is the only child of Arsène Wenger and Annie Brosterhous, a former French Olympic basketball player. She was raised in North London while her father managed Arsenal Football Club. Despite her family’s public profile, she has focused on building an independent scientific career. Her professional achievements in neuroscience and biotechnology have become the defining part of her public identity.
Relationship Status
There is no public confirmation that Léa Wenger is married. No verified information identifies a husband or long-term partner. She has chosen not to discuss her personal relationships in interviews or on professional platforms. Her public presence remains centred on scientific research, biotechnology, and healthcare innovation rather than her private life.
Private Lifestyle
Léa Wenger keeps a low public profile and rarely shares personal information through social media. She maintains a professional presence on LinkedIn, where she highlights her scientific work and leadership at Cyclana Bio. Unlike many public figures, she separates her family background from her professional achievements, allowing her research and entrepreneurship to remain the focus of her career.
Léa Wenger Net Worth
Léa Wenger’s net worth has not been publicly disclosed, and no official financial records confirm her personal wealth. As the co-founder and CEO of Cyclana Bio, her financial profile is closely linked to her biotechnology career rather than public entertainment or sport. While media attention often focuses on her family background, her professional achievements come from scientific research, entrepreneurship, and healthcare innovation. This section explains her known income sources, biotechnology career, and the available information about her estimated wealth.
Income Sources
Léa Wenger earns her professional income through her leadership role at Cyclana Bio, where she serves as Chief Executive Officer. Before founding the company, she worked as an epigenetics scientist at Altos Labs and held academic research positions at the University of Cambridge and the European Bioinformatics Institute. These scientific and executive roles form the foundation of her professional career.
Biotechnology Career
Léa Wenger has built her career through neuroscience research, biotechnology, and medical innovation. Her work focuses on developing therapies for endometriosis, combining scientific expertise with business leadership. As CEO of Cyclana Bio, she leads research, company strategy, and partnerships aimed at advancing women’s health through modern drug discovery and tissue biology.
Estimated Net Worth
There is no verified public estimate of Léa Wenger’s personal net worth. Although Cyclana Bio has reportedly secured significant funding to support its research, this does not represent her personal wealth. Likewise, her father Arsène Wenger’s reported fortune should not be considered part of her individual financial position. Based on publicly available information, the most accurate statement is that Léa Wenger’s net worth has not been officially disclosed.
Health and Public Profile
Léa Wenger has earned recognition through scientific research, biotechnology leadership, and healthcare innovation rather than celebrity status. Although she is widely known as the daughter of Arsène Wenger, she has built an independent career in clinical neuroscience and biotechnology. Public information about her focuses mainly on her research and entrepreneurial work. This section explores her publicly known health status, commitment to women’s health, and professional reputation within the scientific community.
Health Status
There are no publicly reported health concerns involving Léa Wenger. She remains active in biotechnology research and continues leading Cyclana Bio as its Chief Executive Officer. While her company is dedicated to improving treatments for endometriosis, there is no public evidence that her research is linked to her own personal health. She has consistently kept private medical information out of the public domain.
Women’s Health Mission
Léa Wenger has made women’s health the centre of her scientific mission through Cyclana Bio. The company researches the biological causes of endometriosis using tissue biology and extracellular matrix science. Her work aims to develop innovative therapies that address the underlying disease rather than only reducing symptoms. This research reflects her commitment to improving healthcare for millions of women worldwide.
Professional Reputation
Léa Wenger is respected for her achievements in clinical neuroscience, biotechnology, and scientific entrepreneurship. Her academic background at the University of Cambridge, research experience at Altos Labs, and leadership of Cyclana Bio have established her reputation within the biotechnology sector. Rather than relying on her family name, she has built professional recognition through scientific excellence, innovation, and dedication to advancing medical research.
Conclusion
Léa Wenger has built an impressive career through scientific excellence, innovation, and leadership. After completing multiple degrees and a PhD in Clinical Neurosciences at the University of Cambridge, she gained valuable experience at Altos Labs before co-founding Cyclana Bio. Her work focuses on improving treatments for endometriosis, demonstrating a strong commitment to women’s health and biotechnology. Although she is widely recognised as the daughter of Arsène Wenger, her achievements stand on their own through research, entrepreneurship, and medical innovation. As her biotechnology career continues to grow, Léa Wenger remains a promising leader shaping the future of healthcare research.
Frequently Asked Questions
Who is Léa Wenger?
Léa Wenger is a French clinical neuroscientist, biotechnology entrepreneur, and co-founder and CEO of Cyclana Bio.
How old is Léa Wenger?
According to the provided source, Léa Wenger was born in April 1997 and is 29 years old.
Who are Léa Wenger’s parents?
Léa Wenger is the daughter of former Arsenal manager Arsène Wenger and former French Olympic basketball player Annie Brosterhous.
Where did Léa Wenger study?
She studied at the University of Cambridge, where she completed multiple degrees, including a PhD in Clinical Neurosciences.
What degrees does Léa Wenger have?
She earned a BA in Physiology, Development and Neuroscience, completed the Medical Veterinary Sciences Tripos (MVST), and received a PhD in Clinical Neurosciences in 2022.
What is Cyclana Bio?
Cyclana Bio is a Cambridge-based biotechnology company co-founded by Léa Wenger. It focuses on developing new treatments for endometriosis through tissue biology and drug discovery research.
Did Léa Wenger work at Altos Labs?
Yes. After completing her doctorate, Léa Wenger worked as an epigenetics scientist at Altos Labs before founding Cyclana Bio.
Is Léa Wenger married?
There is no public confirmation that Léa Wenger is married.
Does Léa Wenger have a husband?
No verified public information confirms that Léa Wenger has a husband or long-term partner.
What is Léa Wenger’s net worth?
Léa Wenger’s net worth has not been publicly disclosed. There are no verified public estimates of her personal wealth.
Does Léa Wenger have a Wikipedia page?
No. As of 2026, Léa Wenger does not have a dedicated Wikipedia page.
What does Léa Wenger research?
Her research focuses on clinical neuroscience, tissue biology, and developing new therapies for endometriosis through biotechnology.
What is Léa Wenger’s nationality?
Léa Wenger is French.
What is Léa Wenger’s health status?
There are no publicly reported health concerns
